You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SSTR

Showing 1 - 25 of 90
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Semi-automated Segmentation Methods of SSTR PET for Dosimetry

Not yet recruiting
  • Refractory Meningioma
  • To evaluate the SUVmean (Standard Uptake Value) as a predictive factor of the tumor absorbed dose compared to the SUVmax
  • (no location specified)
Sep 8, 2022

SSTR2, FAP, Positron-Emission Tomography Trial in Xiamen (18F-FDG PET/CT, 68Ga-FAPI-LM3 PET/CT)

Recruiting
  • SSTR2
  • +2 more
  • 18F-FDG PET/CT, 68Ga-FAPI-LM3 PET/CT
  • Xiamen, Fujian, China
    The First Affiliated Hospital of Xiamen University
May 24, 2023

Nasopharyngeal Carcinoma Trial in Xiamen (177Lu-EB-LM3 1, 177Lu-EB-LM3 2)

Recruiting
  • SSTR2-positive Tumors
  • 177Lu-LNC1010 1
  • +2 more
  • Xiamen, China
    The First Affiliated Hospital of Xiamen University
Nov 20, 2022

Neuroendocrine Tumors, Paraganglioma, Pheochromocytoma Trial (177Lu-DOTATOC)

Not yet recruiting
  • Neuroendocrine Tumors
  • +2 more
  • (no location specified)
Sep 13, 2023

SCLC,Extensive Stage Trial in Omaha (RYZ101 Dose Level 1, RYZ101 Dose Level 2, RYZ101 Dose Level 3)

Recruiting
  • SCLC,Extensive Stage
  • RYZ101 Dose Level 1
  • +6 more
  • Omaha, Nebraska
    Nebraska Cancer Specialists
Nov 18, 2022

Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor of Pancreas Trial in Iowa City, Rochester

Not yet recruiting
  • Neuroendocrine Tumors
  • +8 more
  • Iowa City, Iowa
  • +1 more
Nov 23, 2022

Gastroenteropancreatic Neuroendocrine Tumor Trial in Stanford (Lutathera, Gallium 68 Dotatate, Computed Tomography (CT))

Suspended
  • Gastroenteropancreatic Neuroendocrine Tumor
  • Stanford, California
    Stanford Cancer Institute Palo Alto
Sep 21, 2022

GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease Trial in United States

Recruiting
  • GEP-NET
  • +6 more
  • Duarte, California
  • +3 more
Jul 28, 2022

Multiple Myeloma Trial in Brussels (Gallium-68 labelled DOTA-conjugated SSTR targeting peptide PET/CT)

Recruiting
  • Multiple Myeloma
  • Gallium-68 labelled DOTA-conjugated SSTR targeting peptide PET/CT
  • Brussels, Belgium
    Jules Bordet Institute
Oct 7, 2021

Small Cell Lung Cancer and Breast Cancer Trial in Worldwide (Satoreotide tetraxetan, Satoreotide trizoxetan)

Terminated
Has Results
  • Small Cell Lung Cancer and Breast Cancer
  • Satoreotide tetraxetan
  • Satoreotide trizoxetan
  • Houston, Texas
  • +7 more
Aug 22, 2022

Meningioma Trial in New York (Ga-68- DOTATATE, Ga-68-DOTATOC)

Recruiting
  • Meningioma
  • New York, New York
    Weill Cornell Medical College of Cornell University
Apr 10, 2022

Lung Cancer, Neuroendocrine Tumor Trial in Beijing (68Ga-NOTA-3P-TATE-RGD)

Recruiting
  • Lung Cancer
  • Neuroendocrine Neoplasm
  • Beijing, Beijing, China
    Peking Union Medical College Hospitall, Chinese Academy of Medic
Mar 30, 2022

Neuroendocrine Tumors Trial in Portland (Cabozantinib, Lu-177)

Not yet recruiting
  • Neuroendocrine Tumors
  • Portland, Oregon
    Providence Portland Cancer Institute - Franz Clinic
Feb 10, 2022

Neuroendocrine Tumor Trial in Houston (AlphaMedix)

Recruiting
  • Neuroendocrine Tumor
  • Houston, Texas
  • +1 more
Aug 17, 2021

Neuroendocrine Tumors Trial (Copper Cu 64 Dotatate)

Approved for marketing
  • Neuroendocrine Tumors
  • Copper Cu 64 Dotatate
  • (no location specified)
Oct 8, 2020

Neuroendocrine Tumors Trial in Worldwide (177Lu-Edotreotide (Peptide Receptor Radionuclide Therapy) PRRT, CAPTEM (Capecitabine

Recruiting
  • Neuroendocrine Tumors
  • 177Lu-Edotreotide (Peptide Receptor Radionuclide Therapy) PRRT
  • +4 more
  • Palo Alto, California
  • +30 more
Dec 14, 2022

Breast Cancer Stage IV Trial in Irvine (Gallium-68)

Recruiting
  • Breast Cancer Stage IV
  • Irvine, California
    Hoag Memorial Hospital Presbyterian
May 26, 2023

Neuroendocrine Tumors Trial in Meldola (PRRT every 5 weeks, PRRT every 8-10 weeks)

Unknown status
  • Neuroendocrine Tumors
  • PRRT every 5 weeks
  • PRRT every 8-10 weeks
  • Meldola, FC, Italy
    Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumor
Apr 20, 2020

Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine

Not yet recruiting
  • Digestive System Neuroendocrine Tumor G1
  • +5 more
  • Tumor Debulking
  • +5 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Aug 23, 2023

Breast Cancer Trial in Innsbruck (Satoreotide trizoxetan)

Terminated
Has Results
  • Breast Cancer
  • Satoreotide trizoxetan
  • Innsbruck, Austria
    Medical University Innsbruck
Aug 18, 2020

68-Ga DOTATATE PET/MRI in Diagnosis and Management of

Recruiting
  • CNS Tumors
  • +6 more
  • Ga68-DOTATATE-PET/MRI
  • New York, New York
    Weill Cornell Medicine
Sep 20, 2022

Neuroendocrine Tumors Trial in Innsbruck, Kraków, Ljubljana ([99mTc]Tc-TECANT1)

Recruiting
  • Neuroendocrine Tumors
  • Innsbruck, Austria
  • +2 more
May 12, 2023

Neuroendocrine Tumors Trial in Warszawa (90Y-DOTATATE, (177Lu-DOTAOTyr3)Octreotate, 90Y DOTATATE and 177Lu DOTATATE (mix each of

Unknown status
  • Neuroendocrine Tumors
  • Warszawa, Poland
    Centrum Diagnostyczno-Lecznicze Gammed
Mar 31, 2020

Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (68Ga-DOTATOC)

Not yet recruiting
  • Advanced Gastroenteropancreatic Neuroendocrine Tumor
  • (no location specified)
Oct 16, 2023

Somatostatin Receptors and GH Receptor Expression on Bone of

Completed
  • Evaluation of the Expression of Somatostatin Receptors and GH Receptor on Bone of Acromegalic Patients
  • Trans-sphenoidal surgery
  • Roma, Italy
    Fondazione Policlinnico Gemelli IRCCS
Apr 6, 2023